carboxymethyl glucan
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
1
Earliest trial started Sep 1, 2014 (NCT02158013)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Unspecified targetAntioxidant
antioxidant
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- carboxymethyl glucan
- carboxymethyl glucan
- myoxinol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03349619 | Phase 4 | Mar 5, 2018 | Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy |
| NCT03683108 | Phase 3 | Dec 31, 2015 | University of Milan |
| NCT02158013 | N/A | Sep 1, 2014 | Sacomed ApS, University of Copenhagen |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Sacomed ApS | For profit | 1 | 0 | 1 | 2014 |
| University of Copenhagen | Academic/Hospital | 1 | 1 | 1 | 2014 |
| University of Milan | Academic/Hospital | 1 | 1 | 1 | 2015 |
4 organizations
Page 1 / 1